Changes in Hong Kong stocks | Kingsley Biotech (01548) will rise more than 5% in the middle of this month and will release results in the first half of this month. CARVYKTI sales soared year on year in the first half of the year

The Zhitong Finance App learned that Kingsley Biotech (01548) rose by more than 5%. As of press release, it had risen 3.95% to HK$19.49, with a turnover of HK$287 million.

According to the news, Kingsley Biotech plans to hold a board meeting on August 15 to approve the interim results. The company previously announced that in the second quarter, LEGENDARY BIOLOGICAL CARVYKTI's sales reached US$657 million, up 49.4% year on year and 10% month on month. Sales for the first half of the year reached US$1,254 million, up 55.1% year over year.